Challenges with Medicare Advantage: Impact on Cancer Treatment Access
Insurance companies have reportedly been removing certain cancer-treatment facilities from their networks before the conclusion of a policy year, causing significant challenges for patients. A Medicare Advantage subscriber highlighted difficulties when switching to Original Medicare, especially when securing a Medigap policy. This issue worsens for patients diagnosed with cancer after a one-year trial period under Medicare Advantage, as Medigap applications are often subject to medical underwriting, leading to potential declinations due to pre-existing conditions like cancer.
Many insurers have excluded specific cancer-care centers from network coverage, impacting patients' abilities to maintain consistent treatment plans. Affected individuals face hurdles transitioning to new insurers, often required to navigate complex procedures for continuity of care. These difficulties are compounded by the procedural inefficiencies highlighted by a patient's struggle to process necessary forms, sometimes only distributed through traditional mail.
Access to Cancer Care Under Medicare Advantage
A recent study by JAMA Network demonstrated that Medicare Advantage enrollees face reduced access to top-tier hospitals for cancer surgeries. The research, covering over 567,000 patients between 2016 and 2022, indicated that enrollees of traditional Medicare were more likely to receive care at high-performing centers. Restricted provider networks tied to Medicare Advantage plans limit access to advanced surgical procedures, such as pancreatic surgeries at leading institutions.
Furthermore, insurers conducting medical underwriting during Medigap enrollment outside the initial open-enrollment period remain critical, potentially leaving patients financially vulnerable by denying coverage or imposing higher costs. Transitioning back to Original Medicare without a Medigap policy can further expose patients to substantial financial risk.
Frank L. Beaman of Faith Community Health System in Texas noted the challenges posed by Medicare Advantage plans, including limited treatment approvals and burdensome administrative processes. Despite claims of covering essential services, these plans can be economically restrictive for medical centers, often resulting in denials due to prior authorization hurdles.
The Centers for Medicare & Medicaid Services (CMS) regularly audits Medicare Advantage plans to ensure regulatory compliance, yet the low appeal rates and subsequent overturning of denials suggest persistent systemic issues. Recent data indicate that most denials are overturned upon appeal, emphasizing the necessity for enrollees to persist in their advocacy.
Ultimately, although Medicare Advantage plans offer an alternative to Original Medicare, they present complex challenges in terms of network adequacy and policyholder cost management. Enrollees must carefully balance coverage options to ensure continued access to essential medical services, navigating the intricate landscape of benefits and restrictions.